Mr Jason Glenn White, LPN | |
59 N Water St, Albion, PA 16401-1214 | |
(814) 756-5616 | |
Not Available |
Full Name | Mr Jason Glenn White |
---|---|
Gender | Male |
Speciality | Licensed Practical Nurse |
Location | 59 N Water St, Albion, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386929289 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | PN283427 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Jason Glenn White, LPN 59 N Water St, Albion, PA 16401-1214 Ph: (814) 756-5616 | Mr Jason Glenn White, LPN 59 N Water St, Albion, PA 16401-1214 Ph: (814) 756-5616 |
News Archive
New research shows genes that make smokers more likely to develop chronic obstructive pulmonary disease (COPD), or emphysema, are also closely linked to an increased likelihood of developing lung cancer, according to studies presented today at the American Thoracic Society's annual meeting.
Brookdale Senior Living Inc. today announced that it has entered into a definitive asset purchase agreement with affiliates of Sunrise Senior Living, Inc.to acquire 21 senior living communities that are currently owned by those affiliates for an aggregate purchase price of $204 million plus customary transaction expenses.
UnitedHealthcare, Coventry, Cigna and Time Insurance Company have each submitted plans with the state to offer health insurance in the federally run exchange in Georgia next year. They join the five holdovers from this year's exchange that are also submitting rates for review: Alliant Health Plans, Blue Cross and Blue Shield of Georgia, Humana, Kaiser Permanente, and Peach State Health Plans. The state's deadline for applications for the Georgia exchange was midnight Monday (Miller, 6/30).
Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam. Those findings are being presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.
› Verified 1 days ago
Becky Lynn Cohick, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 13350 Tracy Rd, Albion, PA 16401 Phone: 814-756-0498 |